Apex Biotechnology Corp. (TPE:1733)
Taiwan · Delayed Price · Currency is TWD 29.40
-0.15 (-0.51%)
Jan 21, 2026, 1:30 PM CST
Apex Biotechnology Revenue
Apex Biotechnology had revenue of 437.21M TWD in the quarter ending September 30, 2025, a decrease of -14.20%. This brings the company's revenue in the last twelve months to 1.96B, up 8.38% year-over-year. In the year 2024, Apex Biotechnology had annual revenue of 1.85B with 10.48% growth.
Revenue (ttm)
1.96B
Revenue Growth
+8.38%
P/S Ratio
1.50
Revenue / Employee
n/a
Employees
n/a
Market Cap
2.94B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.85B | 175.67M | 10.48% |
| Dec 31, 2023 | 1.68B | -567.64M | -25.29% |
| Dec 31, 2022 | 2.24B | 112.52M | 5.28% |
| Dec 31, 2021 | 2.13B | 126.32M | 6.30% |
| Dec 31, 2020 | 2.01B | -193.53M | -8.80% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Bora Pharmaceuticals Co., LTD. | 21.10B |
| Lotus Pharmaceutical | 18.66B |
| PharmaEssentia | 13.82B |
| Center Laboratories | 1.57B |
| Oneness Biotech | 117.33M |
| Polaris Group | 70.83M |
| Lumosa Therapeutics | 42.59M |
| Caliway Biopharmaceuticals | 34.99M |